J. Lewis-wambi and V. Jordan, Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?, Breast Cancer Research, vol.63, issue.112, p.206, 2009.
DOI : 10.1053/j.seminoncol.2005.09.003

C. Li, N. Weiss, J. Stanford, and J. Daling, Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women, Cancer, vol.128, issue.11, pp.2570-2577, 2000.
DOI : 10.1002/1097-0142(20000601)88:11<2570::AID-CNCR20>3.0.CO;2-O

J. Manjer, M. J. Berglund, G. Bondeson, L. Garne, J. Janzon et al., Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy, International Journal of Cancer, vol.151, issue.6, pp.919-941, 2001.
DOI : 10.1002/ijc.1279

C. Chen, N. Weiss, P. Newcomb, W. Barlow, and E. White, Hormone Replacement Therapy in Relation to Breast Cancer, JAMA, vol.287, issue.6, pp.734-775, 2002.
DOI : 10.1001/jama.287.6.734

J. Daling, K. Malone, D. Doody, L. Voigt, L. Bernstein et al., Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma, Cancer, vol.73, issue.12, pp.2455-64, 2002.
DOI : 10.1002/cncr.10984

P. Newcomb, L. Titus-ernstoff, K. Egan, A. Trentham-dietz, J. Baron et al., Postmenopausal estrogen and progestin use in relation to breast cancer risk, Cancer Epidemiol Biomarkers Prev, vol.11, pp.593-600, 2002.

G. Ursin, C. Tseng, A. Paganini-hill, S. Enger, P. Wan et al., Does Menopausal Hormone Replacement Therapy Interact With Known Factors to Increase Risk of Breast Cancer?, Journal of Clinical Oncology, vol.20, issue.3, pp.699-706, 2002.
DOI : 10.1200/JCO.2002.20.3.699

L. Newcomer, P. Newcomb, J. Potter, Y. Yasui, A. Trentham-dietz et al., Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States), Cancer Causes and Control, vol.14, issue.3, pp.225-258, 2003.
DOI : 10.1023/A:1023634907723

C. Li, K. Malone, P. Porter, N. Weiss, M. Tang et al., Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer, JAMA, vol.289, issue.24, pp.3254-263, 2003.
DOI : 10.1001/jama.289.24.3254

A. Tjonneland, J. Christensen, B. Thomsen, A. Olsen, K. Overvad et al., Hormone replacement therapy in relation to breast carcinoma incidence rate ratios, Cancer, vol.80, issue.11, pp.2328-2365, 2004.
DOI : 10.1002/cncr.20250

S. Lee, L. Kolonel, L. Wilkens, P. Wan, B. Henderson et al., Postmenopausal hormone therapy and breast cancer risk: The multiethnic cohort, International Journal of Cancer, vol.289, issue.5, pp.1285-91, 2006.
DOI : 10.1002/ijc.21481

M. Garcia-closas, L. Brinton, J. Lissowska, N. Chatterjee, B. Peplonska et al., Established breast cancer risk factors by clinically important tumour characteristics, British Journal of Cancer, vol.150, issue.1, pp.123-132, 2006.
DOI : 10.1023/A:1008970121595

C. Li, J. Daling, K. Malone, L. Bernstein, P. Marchbanks et al., Relationship between Established Breast Cancer Risk Factors and Risk of Seven Different Histologic Types of Invasive Breast Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.15, issue.5, pp.946-54, 2006.
DOI : 10.1158/1055-9965.EPI-05-0881

G. Reeves, V. Beral, J. Green, T. Gathani, and D. Bull, Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis, The Lancet Oncology, vol.7, issue.11, pp.910-918, 2006.
DOI : 10.1016/S1470-2045(06)70911-1

L. Rosenberg, C. Magnusson, E. Lindstrom, S. Wedren, P. Hall et al., Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study, Breast Cancer Research, vol.91, issue.2, p.11, 2006.
DOI : 10.1093/jnci/91.13.1131

L. Brinton, D. Richesson, M. Leitzmann, G. Gierach, A. Schatzkin et al., Menopausal Hormone Therapy and Breast Cancer Risk in the NIH-AARP Diet and Health Study Cohort, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.11, pp.3150-60, 2008.
DOI : 10.1158/1055-9965.EPI-08-0435

D. Flesch-janys, T. Slanger, E. Mutschelknauss, S. Kropp, N. Obi et al., Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy, International Journal of Cancer, vol.16, issue.4, pp.933-974, 2008.
DOI : 10.1002/ijc.23655

A. Fournier, A. Fabre, S. Mesrine, M. Boutron-ruault, F. Berrino et al., Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor???Defined Invasive Breast Cancer, Journal of Clinical Oncology, vol.26, issue.8, pp.1260-1268, 2008.
DOI : 10.1200/JCO.2007.13.4338
URL : https://hal.archives-ouvertes.fr/inserm-00271114

C. Li, K. Malone, P. Porter, T. Lawton, L. Voigt et al., Relationship between Menopausal Hormone Therapy and Risk of Ductal, Lobular, and Ductal-Lobular Breast Carcinomas, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.1, pp.43-50, 2008.
DOI : 10.1158/1055-9965.EPI-07-0558

E. Calle, H. Feigelson, J. Hildebrand, L. Teras, M. Thun et al., Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype, Cancer, vol.10, issue.5, pp.936-981, 2009.
DOI : 10.1002/cncr.24101

T. Slanger, J. Chang-claude, N. Obi, S. Kropp, J. Berger et al., Menopausal Hormone Therapy and Risk of Clinical Breast Cancer Subtypes, Cancer Epidemiology Biomarkers & Prevention, vol.18, issue.4, pp.1188-96, 2009.
DOI : 10.1158/1055-9965.EPI-09-0002

J. Kotsopoulos, W. Chen, M. Gates, S. Tworoger, S. Hankinson et al., Risk factors for ductal and lobular breast cancer: results from the nurses' health study, Breast Cancer Research, vol.15, issue.6, p.106, 2010.
DOI : 10.1091/mbc.E03-11-0786

A. Phipps, C. Li, K. Kerlikowske, W. Barlow, and D. Buist, Risk Factors for Ductal, Lobular, and Mixed Ductal-Lobular Breast Cancer in a Screening Population, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.6, pp.1643-54, 2010.
DOI : 10.1158/1055-9965.EPI-10-0188

M. Work, I. Andrulis, E. John, J. Hopper, Y. Liao et al., Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry, Breast Cancer Research and Treatment, vol.11, issue.2, pp.1209-1229, 2012.
DOI : 10.1007/s10549-012-2056-y

S. Nyante, C. Dallal, G. Gierach, Y. Park, A. Hollenbeck et al., Risk Factors for Specific Histopathological Types of Postmenopausal Breast Cancer in the NIH-AARP Diet and Health Study, American Journal of Epidemiology, vol.178, issue.3, pp.359-71, 2013.
DOI : 10.1093/aje/kws471

C. Li, J. Daling, K. Haugen, M. Tang, P. Porter et al., Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55???74??years of age, Breast Cancer Research and Treatment, vol.18, issue.2, pp.481-490, 2014.
DOI : 10.1007/s10549-014-2960-4

V. Livolsi, J. Kelsey, D. Fischer, T. Holford, E. Mostow et al., Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer, Cancer, vol.28, issue.9, pp.1937-1977, 1982.
DOI : 10.1002/1097-0142(19820501)49:9<1937::AID-CNCR2820490931>3.0.CO;2-H

M. Ewertz and S. Duffy, Risk of breast cancer in relation to reproductive factors in Denmark, British Journal of Cancer, vol.58, issue.1, pp.99-104, 1988.
DOI : 10.1038/bjc.1988.172

J. Wohlfahrt, H. Mouridsen, P. Andersen, and M. Melbye, Reproductive risk factors for breast cancer by receptor status, histology, laterality and location, International Journal of Cancer, vol.146, issue.1, pp.49-55, 1999.
DOI : 10.1002/(SICI)1097-0215(19990331)81:1<49::AID-IJC10>3.0.CO;2-7

C. Li, K. Malone, P. Porter, N. Weiss, M. Tang et al., Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age, International Journal of Cancer, vol.115, issue.4, pp.647-51, 2003.
DOI : 10.1002/ijc.11465

G. Ursin, L. Bernstein, S. Lord, R. Karim, D. Deapen et al., Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology, British Journal of Cancer, vol.19, issue.3, pp.364-71, 2005.
DOI : 10.1038/sj.bjc.6602712

C. Li, A. Littman, and E. White, Relationship between Age Maximum Height Is Attained, Age at Menarche, and Age at First Full-Term Birth and Breast Cancer Risk, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.10, pp.2144-2153, 2007.
DOI : 10.1158/1055-9965.EPI-07-0242

E. Beaber, V. Holt, K. Malone, P. Porter, J. Daling et al., Reproductive Factors, Age at Maximum Height, and Risk of Three Histologic Types of Breast Cancer, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.12, pp.3427-3461, 2008.
DOI : 10.1158/1055-9965.EPI-08-0641

C. Granstrom, J. Sundquist, and K. Hemminki, Population attributable risks for breast cancer in Swedish women by morphological type, Breast Cancer Research and Treatment, vol.100, issue.2, pp.559-68, 2008.
DOI : 10.1007/s10549-007-9814-2

C. Li, K. Malone, J. Daling, J. Potter, L. Bernstein et al., Timing of Menarche and First Full-Term Birth in Relation to Breast Cancer Risk, American Journal of Epidemiology, vol.167, issue.2, pp.230-239, 2008.
DOI : 10.1093/aje/kwm271

S. Butt, S. Borgquist, L. Anagnostaki, G. Landberg, and J. Manjer, Parity and age at first childbirth in relation to the risk of different breast cancer subgroups, International Journal of Cancer, vol.16, issue.8, pp.1926-1960, 2009.
DOI : 10.1002/ijc.24494

G. Reeves, K. Pirie, J. Green, D. Bull, and V. Beral, Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis, British Journal of Cancer, vol.1, issue.3
DOI : 10.1002/(SICI)1097-0215(19990331)81:1<49::AID-IJC10>3.0.CO;2-7

P. Newcomb, A. Trentham-dietz, J. Hampton, K. Egan, L. Titus-ernstoff et al., Late age at first full term birth is strongly associated with lobular breast cancer, Cancer, vol.93, issue.1 suppl, pp.1946-56, 2011.
DOI : 10.1002/cncr.25728

P. Nasca, S. Liu, M. Baptiste, C. Kwon, H. Jacobson et al., Alcohol Consumption and Breast Cancer: Estrogen Receptor Status and Histology, American Journal of Epidemiology, vol.140, issue.11
DOI : 10.1093/oxfordjournals.aje.a117205

C. Li, K. Malone, P. Porter, N. Weiss, M. Tang et al., The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65?79 years of age, Cancer Epidemiol Biomarkers Prev, vol.12, pp.1061-1067, 2003.

J. Lew, N. Freedman, M. Leitzmann, L. Brinton, R. Hoover et al., Alcohol and Risk of Breast Cancer by Histologic Type and Hormone Receptor Status in Postmenopausal Women: The NIH-AARP Diet and Health Study, American Journal of Epidemiology, vol.170, issue.3, pp.308-325, 2009.
DOI : 10.1093/aje/kwp120

C. Li, R. Chlebowski, M. Freiberg, K. Johnson, L. Kuller et al., Alcohol Consumption and Risk of Postmenopausal Breast Cancer by Subtype: The Women's Health Initiative Observational Study, JNCI Journal of the National Cancer Institute, vol.102, issue.18, pp.1422-1453, 2010.
DOI : 10.1093/jnci/djq316

H. Feigelson, A. Patel, L. Teras, T. Gansler, M. Thun et al., Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women, Cancer, vol.54, issue.1, pp.12-21, 2006.
DOI : 10.1002/cncr.21965

M. Schmidt, K. Steindorf, E. Mutschelknauss, T. Slanger, S. Kropp et al., Physical Activity and Postmenopausal Breast Cancer: Effect Modification by Breast Cancer Subtypes and Effective Periods in Life, Cancer Epidemiology Biomarkers & Prevention, vol.17, issue.12, pp.3402-3412, 2008.
DOI : 10.1158/1055-9965.EPI-08-0479

P. Lichtenstein, N. Holm, P. Verkasalo, A. Iliadou, J. Kaprio et al., Environmental and Heritable Factors in the Causation of Cancer ??? Analyses of Cohorts of Twins from Sweden, Denmark, and Finland, New England Journal of Medicine, vol.343, issue.2, pp.78-85, 2000.
DOI : 10.1056/NEJM200007133430201

F. Couch, K. Nathanson, and K. Offit, Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention, Science, vol.343, issue.6178, pp.1466-70, 2014.
DOI : 10.1126/science.1251827

F. Lalloo and D. Evans, Familial Breast Cancer, Clinical Genetics, vol.364, issue.3, pp.105-119, 2012.
DOI : 10.1111/j.1399-0004.2012.01859.x

M. Tan, J. Mester, J. Ngeow, L. Rybicki, M. Orloff et al., Lifetime Cancer Risks in Individuals with Germline PTEN Mutations, Clinical Cancer Research, vol.18, issue.2, pp.400-407, 2012.
DOI : 10.1158/1078-0432.CCR-11-2283

M. Van-lier, A. Wagner, E. Mathus-vliegen, E. Kuipers, E. Steyerberg et al., High Cancer Risk in Peutz???Jeghers Syndrome: A Systematic Review and Surveillance Recommendations, The American Journal of Gastroenterology, vol.16, issue.6, pp.1258-64, 2010.
DOI : 10.1038/ajg.2009.725

Y. Miki, J. Swensen, D. Shattuck-eidens, P. Futreal, K. Harshman et al., A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182, pp.66-71, 1994.
DOI : 10.1126/science.7545954

R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal et al., Identification of the breast cancer susceptibility gene BRCA2, Nature, vol.72, issue.6559, pp.789-92, 1995.
DOI : 10.1038/378789a0

N. Mavaddat, S. Peock, D. Frost, S. Ellis, R. Platte et al., Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE, JNCI Journal of the National Cancer Institute, vol.105, issue.11, pp.812-834, 2013.
DOI : 10.1093/jnci/djt095

D. Ford, D. Easton, M. Stratton, S. Narod, D. Goldgar et al., Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families, The American Journal of Human Genetics, vol.62, issue.3, pp.676-89, 1998.
DOI : 10.1086/301749

A. Gonzalez-angulo, K. Timms, S. Liu, H. Chen, J. Litton et al., Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer, Clinical Cancer Research, vol.17, issue.5, pp.1082-1091, 2011.
DOI : 10.1158/1078-0432.CCR-10-2560

N. Mavaddat, D. Barrowdale, I. Andrulis, S. Domchek, D. Eccles et al., Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA), Cancer Epidemiology Biomarkers & Prevention, vol.21, issue.1, pp.134-181, 2012.
DOI : 10.1158/1055-9965.EPI-11-0775

J. Kamihara, H. Rana, and J. Garber, Mutations and the Changing Landscape of Li-Fraumeni Syndrome, Human Mutation, vol.31, issue.1-2, pp.654-62, 2014.
DOI : 10.1002/humu.22559

A. Chompret, L. Brugieres, M. Ronsin, M. Gardes, F. Dessarps-freichey et al., P53 germline mutations in childhood cancers and cancer risk for carrier individuals, Br J Cancer, vol.82, pp.1932-1939, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00117136

S. Masciari, D. Dillon, M. Rath, M. Robson, J. Weitzel et al., Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort, Breast Cancer Research and Treatment, vol.365, issue.14, pp.1125-1155, 2012.
DOI : 10.1007/s10549-012-1993-9

D. Evans, A. Moran, R. Hartley, J. Dawson, B. Bulman et al., Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status, British Journal of Cancer, vol.14, issue.7, pp.1091-1099, 2010.
DOI : 10.1186/1471-2407-9-86

L. Cannon-albright, A. Thomas, D. Goldgar, K. Gholami, K. Rowe et al., Familiality of cancer in Utah, Cancer Res, vol.54, pp.2378-85, 1994.

U. Cavallaro and E. Dejana, Adhesion molecule signalling: not always a sticky business, Nature Reviews Molecular Cell Biology, vol.67, issue.3, pp.189-97, 2011.
DOI : 10.1038/nrm3068

G. Berx and R. Van, The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression, Breast Cancer Research, vol.7, issue.5, pp.289-93, 2001.
DOI : 10.1016/S1097-2765(01)00260-X

E. Rakha, A. Patel, D. Powe, A. Benhasouna, A. Green et al., Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the Breast, The American Journal of Surgical Pathology, vol.34, issue.10, pp.1472-1481, 2010.
DOI : 10.1097/PAS.0b013e3181f01916

E. Rakha, T. Teoh, A. Lee, C. Nolan, I. Ellis et al., Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study, Histopathology, vol.9, issue.5, pp.695-701, 2013.
DOI : 10.1111/his.12066

P. Guilford, J. Hopkins, J. Harraway, M. Mcleod, N. Mcleod et al., E-cadherin germline mutations in familial gastric cancer, Nature, vol.392, issue.6674, pp.402-407, 1998.
DOI : 10.1038/32918

S. Gayther, K. Gorringe, S. Ramus, D. Huntsman, F. Roviello et al., Identification of germ-line E-cadherin mutations in gastric cancer families of European origin, Cancer Res, vol.58, pp.4086-4095, 1998.

P. Guilford, J. Hopkins, W. Grady, S. Markowitz, J. Willis et al., E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer, Human Mutation, vol.66, issue.3, pp.249-55, 1999.
DOI : 10.1002/(SICI)1098-1004(1999)14:3<249::AID-HUMU8>3.0.CO;2-9

G. Keller, H. Vogelsang, I. Becker, J. Hutter, K. Ott et al., Diffuse Type Gastric and Lobular Breast Carcinoma in a Familial Gastric Cancer Patient with an E-Cadherin Germline Mutation, The American Journal of Pathology, vol.155, issue.2, pp.337-379, 1999.
DOI : 10.1016/S0002-9440(10)65129-2

F. Richards, S. Mckee, M. Rajpar, T. Cole, D. Evans et al., Germline E-cadherin Gene (CDH1) Mutations Predispose to Familial Gastric Cancer and Colorectal Cancer, Human Molecular Genetics, vol.8, issue.4, pp.607-617, 1999.
DOI : 10.1093/hmg/8.4.607

K. Becker, M. Atkinson, U. Reich, I. Becker, H. Nekarda et al., E-cadherin gene mutations provide clues to diffuse type gastric carcinomas, Cancer Res, vol.54, pp.3845-52, 1994.

V. Kumar, A. Abbas, N. Fausto, R. Mitchell, V. Kumar et al., Pathology of the oral cavity and the gastrointestinal tract Philadelphia: Saunders/Elsiever, Robbins basic pathology, pp.598-607, 2007.

P. Pharoah, P. Guilford, and C. Caldas, Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families, Gastroenterology, vol.121, issue.6, pp.1348-53, 2001.
DOI : 10.1053/gast.2001.29611

P. Kaurah, A. Macmillan, N. Boyd, J. Senz, L. De et al., Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer, JAMA, vol.297, issue.21, pp.2360-72, 2007.
DOI : 10.1001/jama.297.21.2360

G. Suriano, S. Yew, P. Ferreira, J. Senz, P. Kaurah et al., Characterization of a Recurrent Germ Line Mutation of the E-Cadherin Gene: Implications for Genetic Testing and Clinical Management, Clinical Cancer Research, vol.11, issue.15, pp.5401-5410, 2005.
DOI : 10.1158/1078-0432.CCR-05-0247

S. Masciari, N. Larsson, J. Senz, N. Boyd, P. Kaurah et al., Germline E-cadherin mutations in familial lobular breast cancer, Journal of Medical Genetics, vol.44, issue.11, pp.726-757, 2007.
DOI : 10.1136/jmg.2007.051268

P. Benusiglio, D. Malka, E. Rouleau, P. De, B. Buecher et al., germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study, Journal of Medical Genetics, vol.304, issue.7, pp.486-495, 2013.
DOI : 10.1136/jmedgenet-2012-101472

K. Schrader, S. Masciari, N. Boyd, C. Salamanca, J. Senz et al., Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers, Journal of Medical Genetics, vol.48, issue.1, pp.64-72, 2011.
DOI : 10.1136/jmg.2010.079814

R. Fitzgerald, R. Hardwick, D. Huntsman, F. Carneiro, P. Guilford et al., Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research, Journal of Medical Genetics, vol.47, issue.7, pp.436-480, 2010.
DOI : 10.1136/jmg.2009.074237
URL : https://hal.archives-ouvertes.fr/hal-00557381

P. Hebbard, A. Macmillan, D. Huntsman, P. Kaurah, F. Carneiro et al., Prophylactic Total Gastrectomy (PTG) for Hereditary Diffuse Gastric Cancer (HDGC): The Newfoundland Experience with 23 Patients, Annals of Surgical Oncology, vol.247, issue.7, pp.1890-1895, 2009.
DOI : 10.1245/s10434-009-0471-z

H. Fujita, J. Lennerz, D. Chung, D. Patel, V. Deshpande et al., Endoscopic Surveillance of Patients With Hereditary Diffuse Gastric Cancer, The American Journal of Surgical Pathology, vol.36, issue.11, pp.1709-1726, 2012.
DOI : 10.1097/PAS.0b013e31826ca204

J. Balmana, O. Diez, I. Rubio, and F. Cardoso, BRCA in breast cancer: ESMO Clinical Practice Guidelines, Ann Oncol, vol.22, issue.6, pp.31-34, 2011.

E. Sawyer, R. Roylance, C. Petridis, M. Brook, S. Nowinski et al., Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast, PLoS Genetics, vol.26, issue.6, p.1004285, 2014.
DOI : 10.1371/journal.pgen.1004285.s016